The genes of blood coagulation factors have recently been cloned and ~haracterized.~-'~ This has allowed the identification of a number of molecular defects underlying various blood coagulation defi~iencies'~.~~ and rendered possible the analysis of the expression and regulation of these genes.
B mediated by the interaction of several zymogens and cofactors that are serially activated in response to an initial stimulus, thus leading to the conversion of soluble fibrinogen to insoluble fibrin. '-6 The genes of blood coagulation factors have recently been cloned and ~haracterized.~-'~ This has allowed the identification of a number of molecular defects underlying various blood coagulation defi~iencies'~.~~ and rendered possible the analysis of the expression and regulation of these genes.
An overview of the neonatal hemostatic mechanisms is r e p~r t e d .~~. '~ As for the earlier stages of human development, previous studies described the plasma level of a variety of clotting factors in the 12-to 36-week gestational p e r i~d .~~.~ ' We have analyzed the expression of a number of coagulation factors (FX, FIX, FVIII, FVII, a-, B-, y-fibrinogen chains, protein C, and antithrombin I11 [AT 1111) in 5-to 10-week-old human embryos and fetuses a t R N A level. FX, FIX, and FVII were also analyzed at protein level. The results suggest an early activation of the FVII/tissue factor mechanism rather than the FIXa/FVIIIa pathway in embryonic and early fetal life. Particularly, we observed a markedly reduced expression of the FIX gene at both R N A and protein levels in these developmental stages, which contrasts a constantly elevated expression of FX gene. 
MATERIALS AND METHODS
Human embryos and fetuses. These were obtained virtually intact from legal curettage abortions and maintained in Iscove's modified Dulbecco's medium (GIBCO, Grand Island, NY) at 4OC until processing." The women had previously provided fully informed consent for research studies. The age of 5-to 8-week-old embryos was established by morphologic staging according to multiple riter ria."^^' Early fetuses (9 to 10 weeks) were staged on the basis of standard age/crown rump length plots." The dating error was as little as + 2 days. Embryonic-fetal livers (FL) and other organs, dissected under an inverted microscope, were stored in liquid nitrogen.
These were obtained for diagnostic purposes from patients with suspected liver disease (eg, chronic hepatitis, liver carcinoma). Fully informed consent was obtained according to the Declaration of Helsinki as amended in Venice (1983) . This study includes only samples from patients with normal liver histology and clotting factor levels.
FX34 at 65OC) the blots were exposed to Kodak X-Omat film SO-282 for 1 to 4 days at -7OoC in an X-omatic intensifying screen cassette. Probes were removed by washing in 50% formamide solution containing 0.1% SDS at 65OC and the filters rehybridized to a different cDNA probe.
Albumin was used as a hepatic marker. A human ribosomal probe (pHR 28A) was used for normalization of total RNA. Embryonicfetal poly(A)+ RNA level was normalized. using @-actin cDNA probe.42 Because @-actin is expressed at a higher level in fetal than adult samples, this probe was not used for normalization of adult specimens. cDNA lihruries. A A phage gtl0 library was prepared with the poly(A)' RNA lrom 7-week-old human FL. The library, amtaining 1.4 x I@ independent recombinants. was screened" with FIX and FX cDNA probes. Positive clones were subcloned in pGEM-42 vector and sequenced using the didcoxy chain terminating method."
In situ hyhridizotion. Six-to eight-week-old human embryos were fixed in phosphate-buffed saline (PBS)-paraformaldehyde 4%. coated in PBS-5% sucrose. embedded in O.C.T. compound (Miles Scientific, Napewille. IL) and serially cut into 8-rm sections. .OOO KIU/mL Trasylol. and I mg/mL soybean trypsin inhibitor. Tissues were homogenized a t medium speed in a Potter-Elvjeheim grinder for 30 to 60 scconds at 4%. Sheared homogenates were centrifuged twice at 2.000 rpm for 20 minutes a t 4%.
Fetal cord or heart blood was collected in 3.2% sodium citrate and centrifuged a t 10,000 rpm for IO minutes. The plasma was stored at -70°C until wed.
Soluble cytoplasmic fraction and plasma protein lmls were measured by a standard assay (BwRad. Richmond, CA). The same amount of protein was fractionated on 10% SDS-polyacrylamide gelsa and electrophoretically transferred to nitrocellulose filters in Tris-glycine buffer containing 20% methanol and 0.05% SDS." Filters were blocked before detection procedures by nitrocellulose incubation in 5% nonfat dry milk. ' * Immunoreactive proteins were detected by sequential nitrocellulose incubations with commercially available rabbit anti-human antibodies (ASSERA VII. 100 U/mL rabbit serum anti-FVII:Ag; ASSERA IX 20 U/mL rabbit serum anti-FIX:&; ASSERA x IO U/mL rabbit serum anti-FX:Ag; Diagmtica Stago. Asmims. France) and with "'I-protein A (Amersham. UK).M-Filters were washed twice with 50 mmol/L Tris-saline (pH 7.4). once with Tris-saline containing 0.05% Triton X-100 and three times with Tris-saline alone. After the final wash, filters were airdried and autoradiographed using X-Omat SO282 Protein unulysis. 
RESULTS
FIX and FX RNA expression in embryoniefetal liver. FIX expression was analyzed by Northern blot of total or poly(A)' RNA from 5-to IO-week-old FL. The results indicate that this factor is expressed as a single transcript of -3.Okbinboth FLandAL (Fig I) .
The hybridiration signal in FL was always weaker than in AL (Fig I) . However. the level of FIX mRNA slowly increased during the 5-to 10-week period. from 2% to 10% of the adult value (Fig I) . In AL, FIX mRNA represents 0.07% of total mRNA (30 pglpg).
Filter rehybridimion with the FX probe showed a single transcript of 1.7 kb. apparently identical to the corruponding AL mRNA (Fig 2) . The intensity of the FL band was constant in the 5-t o 10-week period. at a level comparable with that observed in AL (Fig 2) . The FX transcript represents 0.01% of total mRNA ( 5 pg/pg).
Screening of 1.4 x 106 clones from a 7-week FL cDNA library with the FX and FIX probe showed 58 FX' and two FIX' clones. The FIX' clones and three FX' clones were plaque-purified: the nucleotide sequences of the embryonic cDNAs were identical to that of their adult counterparts.
Results obtained by Northern and dot blot analyses were further confirmed by in situ hybridization on human FL sections. These were hybridized with "P-or 'S-UTP-labeled RNA probes corresponding to the sense and antisense polarity of FIX and FX. The FX antisense probe provided a strong hybridization signal only in the liver (Fig 3, b. d . and e). Sections hybridized with the FX sense probe were negative (not shown). The FIX antisense probe produced a weak hybridization signal in the liver (Fig 3. c. f. and g) . For No band was daected by Northern blot hybridization of 2.5 pg poly(A)' RNA from 7-to 9-weekold kidney. lung, brain.and heart with both FIX and FX cDNA probe (results not shown).
FIX. FX. and FVII protein expression in embryonic
plasma and liver. FIX and FX levels in 7-to 8-week-old cord plasma and liver were evaluated by Westem blot analysis. Me concentration of plasma and soluble liver proteins was determined. and a standard curve was obtained with graded amounts of normal plasma proteins. t)ecaux we could not easily measure the miniscule plasma volume obtained from embryonic-fetal heart or cord blood. we elcc~ed to electrophorcsc the same amount of embryonicfetal and adult protein rather than the same volume of plasma.
As shown in Fig 4. the anti-human FX antibody (I: I .ooO) under reducing conditions revealed a single band with a relative molecular m a s (Mr) of 40 Kd corresponding to the FX heavy chain. The light chain was not visible in this 10% gel. The FX level in cord plasma is 20% to 40% of the adult value; in the soluble fraction of hepatic cells it is more elevated than in corresponding adult controls. Figure 5 shows the results obtained with the anti-FIX antibody (1:500dilution): a faint band of 62 Kd wasdaected in plasma (40 rg) and liver (so0 pg). In both cases the band intensity was significantly lower than in corresponding adult samples.
To determine whether the embryonic-fetal FX is y-carboxylated, hepatic proteins were subjected to barium citrate fractionation': y-carboxylated proteins adsorb to the insoluble salts, thus leaving the noncarboxylated fraction in solution. The embryonic-fetal adsorbed FX molecules had a molcculat weight identical to that in human plasma. FX was FVII. a vitamin K-dependent protein activating FX. was also analp.
by Western blot in 7-week cord plasma and liver cells and compared with adult controls. A 54-Kd protein was observed in both embryonic and adult samples. The embryonic plasma level was 20% to 40% of the adult value. whereas the concentration in the soluble hepatic fraction was similar to the corresponding adult level (Fig 6) . Thus, the embryonic concentration of FVll in embryonic plasma and liver is clearly correlated with that of FX.
Expression at RNA level of other blood coagulation factors in embryoniefetal liver. We have also evaluated the FL R N A expression of other blood coagulation factors playing a key role in the intrinsic or extrinsic pathway.
Analysis of fibrinogen chain R N A in FL showed two transcripts for the y chain (y and y,): their s i t ! are 1.7 and 1.8 kb. respectively. as previously reported for AL. @-chain is encoded by two major transcripts of 2.3 and I .8 k b presumably the obaerved pattern is the result of a set of transcripts. as previously described.' u-Chain is encoded by a transcript of 2.6 kb. The m R N A level of all three fibrinogen chains showed an increase from 25% to 50%of the adult value in the 5-to 10-week age period. thus indicating a coordinated transcription of the three genes."
A single 8.1-kb FVlll transcript wasdetected in poly(A)' R N A from both 6-to 10-week FL (Fig 7) and 7-to 8-week heart (not shown). The FVlll mRNA level in FL was initially low. but showed an increase in the 6-to 10-week priod.
No transcripts were detected in the poly(A)' RNA (3 pg) from lung. kidney, brain, or placenta (data not shown).
We have also analyt. the expression of protein C and AT 111. ie. the m a t important naturally occurring anticoagulant proteins. Northern blot analysis of 6-to IO-week hepatic RNA showed two protein C transcripts of 2.0 and 1.8 kb; their level increased from 25% to 50% of the adult level in the analyt. period. In AL the protein C mRNA represents 0.02% of the total poly(A)' RNA. AT 111 showed a similar exprcssion curve, with a major I .5-kb transcript.
DISCUSSON
These studies shed light on the expression of blood amgulation facton during human ontogenic development.
We re* that a variety of coagulation factors arc transcribed in embryonic and early fetal human life. ie. at 5 to 10 weeks aner fertilitation (scc Fig 8) .
The size of embryonic-fetal transcripts is apparently identical to that of corresponding adult mRNAs. The nucleotide sequence of FIX and FX mRNA in embryonic-fetal and adult life is also identical.
Blood coagulation factors are expressed at lower level in FL than in AL. Detailed analysisof the RNA abundance at 5
to IO weeks of age showed a similar pattem for the three fibrinogen chains. protein C. and AT 111. which is characterized by a gradual increase from 30% to 50% of adult values.
In contrast. a strikingly dimerent pattern was observed for FIX and FX: FIX mRNA was e x p d at very low level.
For For FL concentration similar to that observed in AL. The correlation of FX and FVll level is not surprising. since the former factor is the main substrate of the latter. ' Our results suggest that the expression of blood coagulation factors is modulated during ontogenic development.
It is well-known that in adult life all blood coagulation factors are required for normal hemostasis. but little is known about the blood coagulation system in the prenatal period.
In embryonic-fetal life the sharply reduced level of FIX, as compared with higher concentrations of both FVll and FX. may indicate that the early activation of FX is directly mediated via the FVlla/tissue factor mechanism rather than the FlXa and FVllla pathway. In this regard, FVll and -T-. -a P tissue factor directly activate FX, whereas activation of FX via FIX requires the interaction of several proteins. Similarly, the adult coagulation mechanism initially involves activation of the extrinsic coagulation pathway, via interaction of tissue factor and FVII, before activation of the intrinsic mechanism." Our studies may also allow interpretation of previous resultson the level of blood coagulation factors in later stages of human ontogenic development. The prenatal period is characterized by a reduction of the proteins of the contact system and the vitamin K-dependent factors: preterm infants (27 to 31 weeks) show a consistent reduction of FIX concentration (17 to 20 IU/dL, ie, 17% to 20% of adult Finally, our studies pave the way to the analysis of regulatory proteins modulating the expression of the genes for coagulation factors in human ontogeny. The similarity of the R N A expression pattern observed for the majority of factors in the 5-to 10-week period suggests a common regulatory protein(s), whereas the sharply lower or higher transcriptional activity of FIX or FX gene, respectively, indicates a role for specific repressor(s) or activator(s). We thank Dr D. Lazzaro for help with the in situ hybridization experiments, P. Alessandri for secretarial assistance, and D. Marinelli for editorial.help.
